Myhep All Tablet is an antiviral medication manufactured by Mylan Pharmaceuticals Pvt Ltd, a subsidiary of Viatris. It is primarily used for the treatment of chronic Hepatitis C Virus (HCV) infection in adults.
Category | Antiviral |
Brand | Mylan |
Ingredient | Sofosbuvir |
Prescription Required | Yes |
Strength | 400/100mg |
Package | 28 Tablets |
Myhep 400/100mg Tablets work by combining two powerful antiviral agents: Sofosbuvir (400 mg) and Velpatasvir (100 mg), which target different stages of the Hepatitis C virus (HCV) life cycle. Sofosbuvir is a NS5B polymerase inhibitor that blocks the viral enzyme responsible for replicating the HCV RNA, effectively halting the virus’s ability to reproduce. Velpatasvir, on the other hand, is a NS5A inhibitor that prevents the virus from assembling and being released from infected liver cells.
Myhep 400/100mg Tablets offer several significant benefits for individuals with chronic Hepatitis C Virus (HCV) infection. The combination of Sofosbuvir and Velpatasvir effectively targets the virus at different stages of its lifecycle, leading to a substantial reduction in viral replication.
Myhep 400/100mg Tablet should not be taken by individuals who are allergic to any of its active ingredients, namely Sofosbuvir or Velpatasvir, or any of the excipients in the tablet. It is contraindicated for people with severe liver impairment (Child-Pugh C) because the medication may not be safe or effective in such cases. Additionally, pregnant women or those who are breastfeeding should only use Myhep under the guidance of a healthcare provider, as its safety during pregnancy and breastfeeding has not been fully established.
Myhep 400/100mg Tablet should be taken exactly as prescribed by your healthcare provider. Typically, it is taken once daily with or without food, at the same time each day, to maintain consistent levels of the medication in your system. The tablet should be swallowed whole with a glass of water; do not chew, crush, or break the tablet.
There are no reviews yet.